Newsletters

  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
R&D Insight

Alan Carr’s August ’20 Antibiotic-Antifungal update: Required reading!

Dear All, I hope everyone is finding a bit of time to go off-line during August … always a good ...
Read More >
JobsWHO

Important WHO job opportunity: Global governance structures for AMR-related work

Dear All, Just below my signature, you will find the details of WHO’s search for a consultant to help them ...
Read More >
FDAR&D Insight

Final FDA LPAD guidance: Same substance, useful clarifications

Dear All, FDA have released the final version of their LPAD (Limited Population Pathway for Antibacterial and Antifungal Drugs, really ...
Read More >
R&D Insight

Beyond the AMR Action Fund: PBS NewsHour and Things for us all to do!

Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), While we’re all thrilled with the announcement of ...
Read More >
R&D InsightWHO

Estimating attributable mortality of resistant bloodstream infections: GLASS (WHO) recommended method

Dear All, WHO’s GLASS Secretariat (Global Antimicrobial Resistance Surveillance System, link) have recently released a standardized method for estimating attributable ...
Read More >
SummariesWonkish

Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials

Dear All (with thanks to Kevin Outterson for co-authoring this newsletter), Last week’s announcement of the AMR Action Fund was ...
Read More >
Push/PullR&D Insight

AMR Action Fund: A $1b down payment from Industry; A call for creation of strong Pull incentives

“The world is changed by your example, not by your opinion” (Paulo Coelho) Dear All, The AMR Action Fund (https://www.amractionfund.com/) ...
Read More >
FDAR&D Insight

Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety

Dear All (wonkish alert … the first 3 segments are non-wonkish but the last 2 are in the wonkish zone ...
Read More >
FDAR&D Insight

FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)

Dear All (wonkish note alert … top-up your coffee and settle in!), Today we have a tour of a recent ...
Read More >
FDAR&D Insight

FDA analysis of 40-years of antibacterial development: Dheman et al.

Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), Just out in CID is a paper in ...
Read More >
R&D Insight

SPIDAAR & ATLAS: Data sharing via AMR Surveillance partnerships

Dear All, Building on the ATLAS database (link) that provides open access to data from 2004 to the present out ...
Read More >
JobsWHO

Six-month consultancy with WHO to support antibiotic stewardship

Dear All, Wow, a news-heavy day … at least two more newsletters this weekend, I think. See below my signature ...
Read More >
R&D Insight

SAVE THE DATE: 9 July launch of a major global AMR Initiative

(Updated on 8 July 2020) Dear All, Mark your calendars now for a major global AMR initiative that will be ...
Read More >
FDAR&D Insight

Final CABP and HABP-VABP guidances from FDA; EU seeks to accelerate access to medicines

Dear All, Some regulatory updates today. From FDA, we have final versions of their CABP and HABP-VABP guidance documents. My ...
Read More >
Can you help?Government Action

NHS England Antibiotic Procurement Pilot: Call for applications!

Dear All, As has been discussed in recent newsletters (link), the UK National Institute for Health and Care Excellence (NICE) ...
Read More >
R&D Insight

National Academies: Nominations sought for ad hoc committee on medical and economic impact of AMR

26 Aug 2020 update: The committe has been named and some additional project commentary posted. Go here for details.  — ...
Read More >
R&D Insight

Perspectives on restoring the antibiotic ecosystem: ACS ID, June 2020 issue

Dear All, The June issue of ACS Infectious Diseases (link) is entirely devoted to the perspectives on how we can ...
Read More >
Jobs

Jobs (mostly in Denmark) supporting global implementation of National Action Plans

Dear All, As recently highlighted in the 2019 reports from the World Bank (Pulling Together to Beat Superbugs, link) and ...
Read More >
Can you help?R&D Insight

Novo REPAIR Impact Fund: Global call is open through 31 July 2020

Dear All, Sharpen your pencils! The Novo REPAIR Impact Fund has just opened its 2020 call for proposals. The focus ...
Read More >
R&D InsightSummaries

Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia

Dear All (wonkish note alert — refresh your coffee before proceeding — with thanks to Kevin Outterson for co-authoring this ...
Read More >
Scroll to Top